Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Receivables (2016 - 2025)

InspireMD (NSPR) has 16 years of Receivables data on record, last reported at $2.4 million in Q3 2025.

  • For Q3 2025, Receivables rose 7.27% year-over-year to $2.4 million; the TTM value through Sep 2025 reached $2.4 million, up 7.27%, while the annual FY2024 figure was $2.3 million, 8.08% down from the prior year.
  • Receivables reached $2.4 million in Q3 2025 per NSPR's latest filing, up from $2.1 million in the prior quarter.
  • Across five years, Receivables topped out at $2.5 million in Q4 2023 and bottomed at $825000.0 in Q1 2021.
  • Average Receivables over 5 years is $1.7 million, with a median of $1.7 million recorded in 2024.
  • The widest YoY moves for Receivables: up 123.31% in 2021, down 19.9% in 2021.
  • A 5-year view of Receivables shows it stood at $1.4 million in 2021, then fell by 10.22% to $1.2 million in 2022, then skyrocketed by 96.63% to $2.5 million in 2023, then dropped by 8.08% to $2.3 million in 2024, then increased by 8.07% to $2.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $2.4 million in Q3 2025, $2.1 million in Q2 2025, and $2.3 million in Q1 2025.